Quadrature Capital’s Guardant Health GH Stock Holding History

Quadrature Capital’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.48M	Buy	+63,165	New	+$6.87M	0.08%	183
2026 Q1	–	Sell	-16,504	Closed	-$1.69M	–	1569
2025 Q4	$1.69M	Buy	+16,504	New	+$1.48M	0.02%	394
2025 Q2	–	Sell	-40,025	Closed	-$1.7M	–	1205
2025 Q1	$1.7M	Buy	+40,025	New	+$1.73M	0.04%	324
2022 Q3	–	Sell	-31,621	Closed	-$1.28M	–	934
2022 Q2	$1.28M	Buy	+31,621	New	+$1.57M	0.05%	268
2022 Q1	–	Sell	-8,713	Closed	-$872K	–	812
2021 Q4	$872K	Sell	8,713 -3,255	-27%	-$337K	0.05%	256
2021 Q3	$1.5M	Buy	+11,968	New	+$1.42M	0.05%	201
2021 Q1	–	Sell	-4,133	Closed	-$533K	–	977
2020 Q4	$533K	Buy	+4,133	New	+$476K	0.03%	469
2019 Q4	–	Sell	-14,020	Closed	-$895K	–	577
2019 Q3	$895K	Sell	14,020 -7,906	-36%	-$696K	0.04%	301
2019 Q2	$1.89M	Buy	+21,926	New	+$1.67M	0.12%	155

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Quadrature Capital's GH Position: Q2 2026 in Review

Quadrature Capital opened a new position in Guardant Health (GH) in Q2 2026: 63,165 shares worth $9.48M. The stake represents 0.08% of the portfolio and ranks #183 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in GH as recently as Q4 2025.

Quadrature Capital first reported a position in GH in Q2 2019 and has held it in 9 quarters since. 601 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Quadrature Capital held 63,165 shares of Guardant Health worth $9.48M as of Q2 2026.
Guardant Health was a new Quadrature Capital position in Q2 2026.
Guardant Health made up 0.08% of Quadrature Capital's portfolio in Q2 2026, its #183 holding.
Quadrature Capital first reported a position in Guardant Health in Q2 2019 and has held it in 9 quarters since.
601 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.